Genomics and Proteomics, Geneva, Switzerland
Event Jan 21
Bringing together experts within the global genomics and proteomics arena, the conference will present data and research results from key clinical studies. Priority issues to be addressed by our exceptional speaker panel include the role of pharmacogenomics in enhancing the drug discovery process, estimating disease risk and developing disease treatment processes, improving target validation, and the impact of genomic technologies such as SNPs, mass spectrometry, biomarkers and microarrays in drug discovery.
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018